Skip to main content
Equibles
WRBY logo

WRBY · Warby Parker Inc.

Track WRBY — free

Use WRBY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$23.29 -0.62 (-2.59%) At close · Sep 3
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.01B
Shares
123.61M

WRBY metrics

72 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$23.29
Market cap
$3.01B

Price action

19 metrics
Price change (1W)
-6.2%
Price change (30D)
-20.1%
Price change (3M)
-1.3%
Price change (6M)
-12.6%
Price change (YTD)
+9.7%
Price change (1Y)
-6.4%
Trailing year
Price change (5Y)
—
52-week high
$30.34
52-week low
$16.49
Change from 52-week high
-21.2%
Change from 52-week low
+45.0%
Annualized volatility
74.4%
Beta
2.2
RSI (14D)
37.3
Price vs SMA 50
-10.8%
Price vs SMA 200
-3.5%
Avg volume (3M)
2.94M
Relative volume
0.7
Average dollar volume
$77.67M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
123.61M

Valuation

12 metrics
P / E (TTM)
398.5
Trailing earnings · reciprocal yield 0.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.3×
reciprocal yield 30.3%
P / book
7.7
reciprocal yield 13.0%
FCF yield
0.7%
TTM · current market cap
Buyback yield
0.0%
P / FCF
138.5
reciprocal yield 0.7%
P / operating cash flow
31.6
reciprocal yield 3.2%
Earnings yield
0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
54.7%
Operating margin
0.2%
Trailing 12 months
Net margin
0.8%
Gross profit (TTM)
$498.49M
Operating profit (TTM)
$1.55M
Net income (TTM)
$7.74M
Trailing 12 months
Diluted EPS (TTM)
$0.06
FCF margin
2.4%
Effective tax rate
21.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-3.67

Growth

11 metrics
Revenue growth YoY
+9.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$911.61M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.6%
Year over year · more shares
Revenue CAGR (3Y)
+13.4%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+28.1%

Quality

14 metrics
Return on equity
2.0%
Return on assets
1.0%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
$55.02M
Free cash flow (TTM)
$21.75M
Quick ratio
2.0
Interest coverage
—
Net debt / EBITDA
-5.3
Return on invested capital
—
Trailing 12 months
Net cash
$292.67M
Latest balance sheet
Cash & equivalents
$292.67M
Total assets
$772.32M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$95.36M
Capital expenditures (TTM)
$73.61M
R&D (TTM)
—
SG&A (TTM)
$496.94M
Stock compensation (TTM)
$34.60M
R&D / revenue
—
Stock compensation / revenue
3.8%

Ownership (13F)

3 metrics
13F filers
303
13F filer change QoQ
-3
Institutional ownership
103.8%

Short interest

3 metrics
Short interest
14.7%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$17.69M
Insider-sentiment score
48 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1504776 CUSIP 93403J106 13F (30d) 230 filings 229 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)